|Articles|April 19, 2006

Smith & Nephew Advanced Wound Management Appoints David Hoffman to Lead Business Development

HULL, England, and LARGO, Fla. -- Smith & Nephew's Advanced Wound Management division announces the appointment of David Hoffman as senior vice president of business development and strategic planning.

Hoffman joins Smith & Nephew from Boston Scientific Corporation where he has worked for 10 years most recently in their Endosurgery Group where he has been leading their new market development and strategic planning activity. Prior to his time with BSC he worked for Baxter Healthcare primarily in sales and international marketing roles.

"David has worked in the medical device industry for over 20 years in areas such as endoscopy, vascular, surgery and hospital supply. In that time he has gained a broad range of experience in strategic planning, business development, global marketing, market development for emerging technologies and sales management. He will be a valuable asset to Smith & Nephew," commented Joe Woody, president of advanced wound management.

Hoffman holds a BS in economics from Northwestern University and an MBA from Butler University. He resides in Concord, Mass. with his wife and children.

 


Related to this article

Donald Sipp, Jr, MBA, RESE, CHESP, CHTI-2, CMIP, PMP, and David Green  (Image credit: author)
“Cutting” waste shouldn’t mean cutting people. At AHE Exchange26, David Green and Donald Sipp explored how EVS departments can improve performance by strengthening workplace culture, empowering employees, eliminating inefficient processes, and understanding EVS’s critical role in patient throughput. One case study showed bed turnaround times falling from nearly 2 hours to less than an hour, but the larger lesson wasn't simply about speed. High-performing EVS operations begin with a strong foundation.
Infection preventionists in full PPE with children in DRC.  (Image credit: author with AI)
Nearly 4 months into the DRC's Bundibugyo virus disease outbreak, some indicators suggest transmission may be slowing. But shifting hotspots, treatment-center capacity problems, community deaths, and incomplete surveillance data show why national case totals alone cannot determine whether containment has been achieved.